×

Pamorelin 11.25mg

Pamorelin 11.25mg

Each vial contains: Triptorelin (as embonate) 11.25 mg

Categories: ,

Description

  • Palliative treatment of locally advanced, non-metastatic hormone dependent prostate cancer.
  • Adjuvant treatment of metastatic hormone dependent prostate cancer.
  • Adjuvant treatment to radio therapy in patients with high risk localized or locally advanced prostate cancer.
  • Treatment of endometriosis

Related products